{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:40:38Z","timestamp":1793497238559,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia is a multifactorial disease involving interactions between genetic and environmental factors. Vitamin D has recently been linked to many metabolic diseases and schizophrenia. Vitamin D plays essential roles in the brain in the context of neuroplasticity, neurotransmitter biosynthesis, neuroprotection, and neurotransmission. Vitamin D receptors are demonstrated in most brain regions that are related to schizophrenia. However, very few studies in the literature examine the effects of 25-hydroxyvitamin D (25OHD) on schizophrenia symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study aimed to examine the effects of vitamin D replacement on positive, negative, and cognitive symptoms of schizophrenia. Serum 25OHD levels of 52 schizophrenia patients were measured. SANS and SAPS were used to evaluate the severity of schizophrenia symptoms, and the Wisconsin Card Sorting Test: CV4 was used for cognitive assessment. The study was completed with 40 patients for various reasons. The patients whose serum 25OHD reached optimal levels after vitamin D replacement were reevaluated with the same scales in terms of symptom severity. The SPSS 25 package program was used for statistical analysis. The Independent-Samples t-test was used to examine the relationship between the variables that may affect vitamin D levels and the vitamin D level and to examine whether vitamin D levels had an initial effect on the scale scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean plasma 25OHD levels of the patients was 17.87\u2009\u00b1\u20095.54. A statistically significant relationship was found only between the duration of sunlight exposure and 25 OHD level (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The mean SANS and SAPS scores of the participants after 25OHD replacement (23.60\u2009\u00b1\u200915.51 and 7.78\u2009\u00b1\u20098.84, respectively) were statistically significantly lower than mean SANS and SAPS scores before replacement (51.45\u2009\u00b1\u200917.96 and 18.58\u2009\u00b1\u200915.59, respectively) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for all). Only the total attention score was significantly improved after replacement (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data obtained from our study suggest that eliminating the 25OHD deficiency together with antipsychotic treatment can improve the total attention span and positive and negative symptoms in schizophrenia. The 25OHD levels should be regularly measured, replacement should be started when necessary, and the patients should be encouraged to get sunlight exposure to keep optimal 25OHD levels.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-021-03308-w","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T05:03:06Z","timestamp":1623733386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The psychotropic effect of vitamin D\u00a0supplementation on schizophrenia symptoms"],"prefix":"10.1186","volume":"21","author":[{"given":"Aras","family":"Neriman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilmaz","family":"Hakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ucuncu","family":"Ozge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"2","key":"3308_CR1","first-page":"251","volume":"26","author":"G Karaku\u015f","year":"2017","unstructured":"Karaku\u015f G, Kocal Y, Sert D. Schizophrenia: etiology, clinical features and treatment. Arch. Med. Rev. J. 2017;26(2):251\u201367.","journal-title":"Arch. Med. Rev. J."},{"issue":"10","key":"3308_CR2","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1210\/jc.2014-1887","volume":"99","author":"G Valipour","year":"2014","unstructured":"Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014;99(10):3863\u201372. https:\/\/doi.org\/10.1210\/jc.2014-1887.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3308_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/schbul\/sbp023","volume":"35","author":"DK Kinney","year":"2009","unstructured":"Kinney DK, Teixeira P, Hsu D, Napoleon SC, Crowley DJ, Miller A, et al. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin D deficiency and infections? Schizophr Bull. 2009;35(3):582\u201395. https:\/\/doi.org\/10.1093\/schbul\/sbp023.","journal-title":"Schizophr Bull"},{"key":"3308_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.psychres.2016.12.052","volume":"249","author":"J Adamson","year":"2017","unstructured":"Adamson J, Lally J, Gaughran F, Krivoy A, Allen L, Stubbs B. Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Res. 2017;249:78\u201385. https:\/\/doi.org\/10.1016\/j.psychres.2016.12.052.","journal-title":"Psychiatry Res"},{"issue":"1","key":"3308_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/eb-2015-102117","volume":"19","author":"M Chiang","year":"2016","unstructured":"Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016;19(1):6\u20139. https:\/\/doi.org\/10.1136\/eb-2015-102117.","journal-title":"Evid Based Ment Health"},{"key":"3308_CR6","doi-asserted-by":"publisher","first-page":"S278","DOI":"10.1016\/j.psyneuen.2009.07.003","volume":"34","author":"P Tuohimaa","year":"2009","unstructured":"Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology. 2009;34:S278\u201386. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.07.003.","journal-title":"Psychoneuroendocrinology."},{"issue":"6","key":"3308_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/2045125314553612","volume":"4","author":"RN Y\u00fcksel","year":"2014","unstructured":"Y\u00fcksel RN, Altunsoy N, Tikir B, Cingi K\u00fcl\u00fck M, Unal K, Goka S, et al. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol. 2014;4(6):268\u201375. https:\/\/doi.org\/10.1177\/2045125314553612.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3308_CR8","first-page":"259","volume":"22","author":"A Tellio\u011flu","year":"2013","unstructured":"Tellio\u011flu A, Ba\u015faran S. Vitamin D in the light of current knowledge. Arch Med Rev J. 2013;22:259\u201371.","journal-title":"Arch Med Rev J"},{"issue":"1-3","key":"3308_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.schres.2016.08.024","volume":"178","author":"M Nerhus","year":"2016","unstructured":"Nerhus M, Berg AO, Kvitland LR, Dieset I, Hope S, Dahl SR, et al. Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophr Res. 2016;178(1-3):44\u20139. https:\/\/doi.org\/10.1016\/j.schres.2016.08.024.","journal-title":"Schizophr Res"},{"key":"3308_CR10","unstructured":"T\u00fcrkiye Endokrinoloji ve Metabolizma Derne\u011fi (TEMD). Osteoporoz ve Metabolik Kemik Hastal\u0131klar\u0131 Tan\u0131 ve Tedavi K\u0131lavuzu. Ankara. 2016 http:\/\/temd.org.tr\/admin\/uploads\/tbl_kilavuz\/METABOLIK_KH_BOOK_web_.pdf (accessed 21 September 2020)."},{"issue":"5","key":"3308_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/eip.12122","volume":"9","author":"KA Graham","year":"2015","unstructured":"Graham KA, Keefe RS, Lieberman JA, Calikoglu AS, Lansing KM, Perkins DO. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Interv Psychiatry. 2015;9(5):397\u2013405. https:\/\/doi.org\/10.1111\/eip.12122.","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"3308_CR12","first-page":"1","volume":"9","author":"S Asilsoy","year":"2011","unstructured":"Asilsoy S. Vitamin D and allergic diseases. Asthma Allergy Immunol. 2011;9(1):1\u20137.","journal-title":"Asthma Allergy Immunol"},{"issue":"5","key":"3308_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/nan.12020","volume":"39","author":"GC DeLuca","year":"2013","unstructured":"DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC. The role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458\u201384. https:\/\/doi.org\/10.1111\/nan.12020.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"3308_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.wnr.0000129370.04248.92","volume":"15","author":"AV Kalueff","year":"2004","unstructured":"Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport. 2004;15(8):1271\u20134. https:\/\/doi.org\/10.1097\/01.wnr.0000129370.04248.92.","journal-title":"Neuroreport."},{"issue":"4","key":"3308_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tins.2019.01.003","volume":"42","author":"PE Mayne","year":"2019","unstructured":"Mayne PE, Burne TH. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness. Trends Neurosci. 2019;42(4):293\u2013306. https:\/\/doi.org\/10.1016\/j.tins.2019.01.003.","journal-title":"Trends Neurosci"},{"key":"3308_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pscychresns.2015.06.006","volume":"233","author":"V Shivakumar","year":"2015","unstructured":"Shivakumar V, Kalmady SV, Amaresha AC, Jose D, Narayanaswamy JC, Agarwal SM, et al. Serum vitamin D and hippocampal gray matter volume in schizophrenia. Psychiatry Res Neuroimaging. 2015;233:75\u2013179.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"2","key":"3308_CR17","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00188.2017","volume":"314","author":"MJ Berridge","year":"2018","unstructured":"Berridge MJ. Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia). Am J Physiol Cell Physiol. 2018;314(2):C135\u201351. https:\/\/doi.org\/10.1152\/ajpcell.00188.2017.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"3308_CR18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.psyneuen.2006.05.006","volume":"31","author":"DW Eyles","year":"2006","unstructured":"Eyles DW, Rogers F, Buller K, McGrath JJ, Ko P, French K, et al. Developmental vitamin D (DVD) deficiency in the rat alters adult behaviour independently of HPA function. Psychoneuroendocrinology. 2006;31(8):958\u201364. https:\/\/doi.org\/10.1016\/j.psyneuen.2006.05.006.","journal-title":"Psychoneuroendocrinology."},{"issue":"2","key":"3308_CR19","first-page":"88","volume":"14","author":"D Itzhaky","year":"2012","unstructured":"Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J. 2012;14(2):88\u201392.","journal-title":"Isr Med Assoc J"},{"issue":"2\u20133","key":"3308_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.schres.2014.08.031","volume":"159","author":"K Cieslak","year":"2014","unstructured":"Cieslak K, Feingold J, Antonius D, Walsh-Messinger J, Dracxler R, Rosedale M, et al. Low vitamin D levels predict clinical features of schizophrenia. Schizophr Res. 2014;159(2\u20133):543\u20135. https:\/\/doi.org\/10.1016\/j.schres.2014.08.031.","journal-title":"Schizophr Res"},{"issue":"3","key":"3308_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/children1030261","volume":"1","author":"A Villagomez","year":"2014","unstructured":"Villagomez A, Ramtekkar U. Iron, magnesium, vitamin D, and zinc deficiencies in children presenting with symptoms of attention-deficit\/hyperactivity disorder. Children. 2014;1(3):261\u201379. https:\/\/doi.org\/10.3390\/children1030261.","journal-title":"Children."},{"issue":"1","key":"3308_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1179\/1476830514Y.0000000109","volume":"18","author":"E Pl\u00f3zer","year":"2015","unstructured":"Pl\u00f3zer E, Altb\u00e4cker A, Darnai G, Perlaki G, Orsi G, Nagy SA, et al. Intracranial volume inversely correlates with serum 25 (OH) D level in healthy young women. Nutr Neurosci. 2015;18(1):37\u201340. https:\/\/doi.org\/10.1179\/1476830514Y.0000000109.","journal-title":"Nutr Neurosci"},{"key":"3308_CR23","doi-asserted-by":"publisher","unstructured":"Croll PH, Boelens M, Vernooij MW, van de Rest O, Zillikens MC, Ikram MA, et al. Associations of vitamin D deficiency with MRI markers of brain health in a community sample. Clin Nutr In press. 2021. https:\/\/doi.org\/10.1016\/j.clnu.2020.04.027.","DOI":"10.1016\/j.clnu.2020.04.027"},{"key":"3308_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fncel.2013.00111","volume":"7","author":"JP Kesby","year":"2013","unstructured":"Kesby JP, Cui X, Burne TH, Eyles DW. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front Cell Neurosci. 2013;7:111.","journal-title":"Front Cell Neurosci"},{"issue":"jan11 1","key":"3308_CR25","doi-asserted-by":"publisher","first-page":"b5664","DOI":"10.1136\/bmj.b5664","volume":"340","author":"SH Pearce","year":"2010","unstructured":"Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ. 2010;340(jan11 1):b5664. https:\/\/doi.org\/10.1136\/bmj.b5664.","journal-title":"BMJ"},{"issue":"2","key":"3308_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4274\/tod.94830","volume":"20","author":"F Fidan","year":"2014","unstructured":"Fidan F, Alkan BM, Tosun A. Pandemic era: vitamin D deficiency and insufficiency. Turk J Osteoporos. 2014;20(2):71\u20134. https:\/\/doi.org\/10.4274\/tod.94830.","journal-title":"Turk J Osteoporos"},{"issue":"4","key":"3308_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3945\/ajcn.115.120873","volume":"103","author":"KD Cashman","year":"2016","unstructured":"Cashman KD, Dowling KG, \u0160krab\u00e1kov\u00e1 Z, Gonzalez-Gross M, Valtue\u00f1a J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033\u201344. https:\/\/doi.org\/10.3945\/ajcn.115.120873.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3308_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.schres.2014.03.017","volume":"156","author":"JD Clelland","year":"2014","unstructured":"Clelland JD, Read LL, Drouet V, Kelly A, Duff KE, Nadrich RH, et al. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association. Schizophr Res. 2014;156(1):15\u201322. https:\/\/doi.org\/10.1016\/j.schres.2014.03.017.","journal-title":"Schizophr Res"},{"issue":"1","key":"3308_CR29","doi-asserted-by":"publisher","first-page":"26496","DOI":"10.1038\/srep26496","volume":"6","author":"AE Taylor","year":"2016","unstructured":"Taylor AE, Burgess S, Ware JJ, Gage SH, Richards JB, Smith GD, et al. Investigating causality in the association between 25 (OH) D and schizophrenia. Sci Rep. 2016;6(1):26496. https:\/\/doi.org\/10.1038\/srep26496.","journal-title":"Sci Rep"},{"key":"3308_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fpsyt.2017.00105","volume":"8","author":"KS Akinlade","year":"2017","unstructured":"Akinlade KS, Olaniyan OA, Lasebikan VO, Rahamon SK. Vitamin D levels in different severity groups of schizophrenia. Front Psychiatry. 2017;8:105. https:\/\/doi.org\/10.3389\/fpsyt.2017.00105.","journal-title":"Front Psychiatry"},{"issue":"3","key":"3308_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.32383\/appdr\/100662","volume":"76","author":"S Ristic","year":"2019","unstructured":"Ristic S, Milovanovic D, Janjic V, Pirkovic MS, Vukomanovic IS, Curcic S, et al. Antipsychotics and low vitamin D-additional data calling for drug causality assessment. Acta Pol Pharm. 2019;76(3):605\u20139. https:\/\/doi.org\/10.32383\/appdr\/100662.","journal-title":"Acta Pol Pharm"},{"key":"3308_CR32","volume-title":"The scale for the assessment of negative symptoms (SANS)","author":"N Andreasen","year":"1983","unstructured":"Andreasen N. The scale for the assessment of negative symptoms (SANS). Iowa City, Iowa: The University of Iowa; 1983."},{"key":"3308_CR33","volume-title":"The scale for the assessment of positive symptoms (SAPS)","author":"N Andreasen","year":"1984","unstructured":"Andreasen N. The scale for the assessment of positive symptoms (SAPS). Iowa City, Iowa: The University of Iowa; 1984."},{"key":"3308_CR34","first-page":"16","volume":"4","author":"S Erkoc","year":"1991","unstructured":"Erkoc S, Arkonac O, Atakl\u0131 C, Ozmen E. The validity and reliability of the scale for the assessment of negative symptoms (in Turkish). Dusunen Adam. 1991;4:16\u20139.","journal-title":"Dusunen Adam"},{"key":"3308_CR35","first-page":"20","volume":"4","author":"S Erkoc","year":"1991","unstructured":"Erkoc S, Arkonac O, Atakl\u0131 C, Ozmen E. The validity and reliability of the scale for the assessment of positive symptoms (in Turkish). Dusunen Adam. 1991;4:20\u20134.","journal-title":"Dusunen Adam."},{"key":"3308_CR36","first-page":"1","volume":"4","author":"RK Heaton","year":"1993","unstructured":"Heaton RK, Staff PAR. Wisconsin card sorting test: computer version 2. Odessa: Psychological Assessment Resources. 1993;4:1\u20134.","journal-title":"Odessa: Psychological Assessment Resources"},{"key":"3308_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ebiom.2017.11.027","volume":"26","author":"A Krivoy","year":"2017","unstructured":"Krivoy A, Onn R, Vilner Y, Hochman E, Weizman S, Paz A, et al. Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial. EBioMedicine. 2017;26:138\u201345. https:\/\/doi.org\/10.1016\/j.ebiom.2017.11.027.","journal-title":"EBioMedicine."},{"key":"3308_CR38","first-page":"941","volume":"15","author":"F Sheikhmoonesi","year":"2016","unstructured":"Sheikhmoonesi F, Zarghami M, Mamashli S, Charati JY, Hamzehpour R, Fattahi S, et al. Effectiveness of vitamin D supplement therapy in chronic stable schizophrenic male patients: a randomized controlled trial. Iran J Pharm Sci. 2016;15:941.","journal-title":"Iran J Pharm Sci"},{"issue":"1","key":"3308_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13063-019-3758-9","volume":"21","author":"F Gaughran","year":"2020","unstructured":"Gaughran F, Stringer D, Berk M, Smith S, Taylor D, Whiskey E, et al. Vitamin D supplementation compared to placebo in people with first episode psychosis-neuroprotection design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial. Trials. 2020;21(1):14. https:\/\/doi.org\/10.1186\/s13063-019-3758-9.","journal-title":"Trials."},{"key":"3308_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jocn.2019.04.031","volume":"65","author":"AB Yazici","year":"2019","unstructured":"Yazici AB, Ciner OA, Yazici E, Cilli AS, Dogan B, Erol A. Comparison of vitamin B12, vitamin D and folic acid blood levels in patients with schizophrenia, drug addiction and controls. J Clin Neurosci. 2019;65:11\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.031.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"3308_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3109\/08039488.2015.1086023","volume":"70","author":"JP Bogers","year":"2016","unstructured":"Bogers JP, Bostoen T, Broekman TG. Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia. Nord J Psychiatry. 2016;70(4):262\u20136. https:\/\/doi.org\/10.3109\/08039488.2015.1086023.","journal-title":"Nord J Psychiatry"},{"issue":"1","key":"3308_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.schres.2013.07.017","volume":"150","author":"MB Murri","year":"2013","unstructured":"Murri MB, Respino M, Masotti M, Innamorati M, Mondelli V, Pariante C, et al. Vitamin D and psychosis: mini meta-analysis. Schizophr Res. 2013;150(1):235\u20139. https:\/\/doi.org\/10.1016\/j.schres.2013.07.017.","journal-title":"Schizophr Res"},{"issue":"10","key":"3308_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165284","volume":"11","author":"S Do\u011fan Bulut","year":"2016","unstructured":"Do\u011fan Bulut S, Bulut S, G\u00f6rkem Atalan D, Berkol T, G\u00fcr\u00e7ay E, T\u00fcrker T, et al. The relationship between symptom severity and low vitamin D levels in patients with schizophrenia. PLoS One. 2016;11(10):e0165284. https:\/\/doi.org\/10.1371\/journal.pone.0165284.","journal-title":"PLoS One"},{"key":"3308_CR44","unstructured":"Republic of Turkey Governorship of Trabzon (RTGT), 2020. Cografi Ozellikler. http:\/\/www.trabzon.gov.tr\/cografi-ozellikler (accessed 23 September 2020)."},{"issue":"9","key":"3308_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1177\/0004867416681853","volume":"51","author":"S Suetani","year":"2017","unstructured":"Suetani S, Saha S, Eyles DW, Scott JG, McGrath JJ. Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian survey of high impact psychosis. Aust N Z J Psychiatry. 2017;51(9):921\u20139. https:\/\/doi.org\/10.1177\/0004867416681853.","journal-title":"Aust N Z J Psychiatry"},{"key":"3308_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/1028415X.2019.1580830","volume":"23","author":"M Zoghbi","year":"2019","unstructured":"Zoghbi M, Haddad C, Hallit S, Nabout R, Medlej-Hashim M, Hachem D, et al. Cognition and physical functioning in patients with schizophrenia: any role for vitamin D? Nutr Neurosci. 2019;23:911\u20139.","journal-title":"Nutr Neurosci"},{"issue":"8","key":"3308_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200250","volume":"13","author":"AO Berg","year":"2018","unstructured":"Berg AO, J\u00f8rgensen KN, Nerhus M, Athanasiu L, Popejoy AB, Bettella F, et al. Vitamin D levels, brain volume, and genetic architecture in patients with psychosis. PLoS One. 2018;13(8):e0200250. https:\/\/doi.org\/10.1371\/journal.pone.0200250.","journal-title":"PLoS One"},{"key":"3308_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fpsyt.2018.00392","volume":"9","author":"G Fond","year":"2018","unstructured":"Fond G, Lan\u00e7on C, Auquier P, Boyer L. C-reactive protein as a peripheral biomarker in schizophrenia. An updated systematic review Front Psychiatry. 2018;9:392. https:\/\/doi.org\/10.3389\/fpsyt.2018.00392.","journal-title":"An updated systematic review Front Psychiatry"},{"key":"3308_CR49","doi-asserted-by":"crossref","unstructured":"Coentre R, Canelas da Silva I. Symptomatic correlates of Vitamin D deficiency in first-episode psychosis. Psychiatry J. 2019;7839287.","DOI":"10.1155\/2019\/7839287"},{"key":"3308_CR50","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.psychres.2016.07.003","volume":"243","author":"JY Yee","year":"2016","unstructured":"Yee JY, See YM, Rashid NAA, Neelamekam S, Lee J. Association between serum levels of bioavailable vitamin D and negative symptoms in first-episode psychosis. Psychiatry Res. 2016;243:390\u20134. https:\/\/doi.org\/10.1016\/j.psychres.2016.07.003.","journal-title":"Psychiatry Res"},{"issue":"1","key":"3308_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15562\/bmj.v7i1.921","volume":"7","author":"N Prasanty","year":"2018","unstructured":"Prasanty N, Amin MM, Effendy E, Simbolon MJ. Low vitamin D serum level increases symptoms severity in schizophrenic patients measured by positive and negative symptoms scale (PANSS) in Batak tribe Sumatera Utara. Medan-Indonesia Bali Med J. 2018;7(1):249\u201354. https:\/\/doi.org\/10.15562\/bmj.v7i1.921.","journal-title":"Medan-Indonesia Bali Med J"},{"issue":"1","key":"3308_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.XME.0000508433.27202.4e","volume":"24","author":"M El Sayed El Taweel","year":"2017","unstructured":"El Sayed El Taweel M, El Shafei T. Relationship between vitamin D status and psychopathology in patients with first-episode schizophrenia: a cross-sectional study. Middle East Curr Psychiatry. 2017;24(1):43\u20138. https:\/\/doi.org\/10.1097\/01.XME.0000508433.27202.4e.","journal-title":"Middle East Curr Psychiatry"},{"issue":"9","key":"3308_CR53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/01616412.2019.1622872","volume":"41","author":"G Bivona","year":"2019","unstructured":"Bivona G, Gambino CM, Iacolino G, Ciaccio M. Vitamin D and the nervous system. Neurol Res. 2019;41(9):827\u201335. https:\/\/doi.org\/10.1080\/01616412.2019.1622872.","journal-title":"Neurol Res"},{"issue":"1","key":"3308_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.exger.2011.11.004","volume":"47","author":"LP Breitling","year":"2012","unstructured":"Breitling LP, Perna L, M\u00fcller H, Raum E, Kliegel M, Brenner H. Vitamin D and cognitive functioning in the elderly population in Germany. Exp Gerontol. 2012;47(1):122\u20137. https:\/\/doi.org\/10.1016\/j.exger.2011.11.004.","journal-title":"Exp Gerontol"},{"issue":"9","key":"3308_CR55","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/ene.12460","volume":"21","author":"AL Schneider","year":"2014","unstructured":"Schneider AL, Lutsey PL, Alonso A, Gottesman RF, Sharrett AR, Carson KA, et al. Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC brain MRI study. Eur J Neurol. 2014;21(9):1211\u2013e70. https:\/\/doi.org\/10.1111\/ene.12460.","journal-title":"Eur J Neurol"},{"key":"3308_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clnesp.2017.11.011","volume":"23","author":"PP Lerner","year":"2018","unstructured":"Lerner PP, Sharony L, Miodownik C. Association between mental disorders, cognitive disturbances and vitamin D serum level: current state. Clin Nutr ESPEN. 2018;23:89\u2013102. https:\/\/doi.org\/10.1016\/j.clnesp.2017.11.011.","journal-title":"Clin Nutr ESPEN"},{"key":"3308_CR57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jsbmb.2014.11.004","volume":"148","author":"X Cui","year":"2015","unstructured":"Cui X, Gooch H, Groves NJ, Sah P, Burne TH, Eyles DW, et al. Vitamin D and the brain: key questions for future research. J Steroid Biochem Mol Biol. 2015;148:305\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2\u20133","key":"3308_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.schres.2013.08.036","volume":"150","author":"M Crews","year":"2013","unstructured":"Crews M, Lally J, Gardner-Sood P, Howes O, Bonaccorso S, Smith S, et al. Vitamin D deficiency in first episode psychosis: a case\u2013control study. Schizophr Res. 2013;150(2\u20133):533\u20137. https:\/\/doi.org\/10.1016\/j.schres.2013.08.036.","journal-title":"Schizophr Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T05:03:41Z","timestamp":1623733421000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3308"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03308-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out under relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Ethics Committee of the Trabzon Kanuni Training and Research Hospital. All subjects were informed about the study and informed consent was obtained from all participants or legally authorized representatives for illiterate participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"309"}}